Zobrazeno 1 - 10
of 445
pro vyhledávání: '"J. Esteva"'
Publikováno v:
The Lancet Regional Health. Americas, Vol 32, Iss , Pp 100712- (2024)
Summary: Background: Understanding the survival outcomes associated with breast-conserving therapy (BCT) and mastectomy after preoperative systemic therapy (PST) enables clinicians to provide more personalized treatment recommendations. However, lack
Externí odkaz:
https://doaj.org/article/c6ff81558cca4cf8937cb01a0e2a20d9
Publikováno v:
Cancer Reports.
Autor:
Eddy S. Yang, Susan E. Nozell, Albert F. LoBuglio, Rachel Schiff, C. Kent Osborne, Francisco J. Esteva, Andres Forero, Ling Zeng, Tiffiny S. Cooper, Rajani Rajbhandari, Zhuo Zhang, Monica E. Wielgos
Supplemental Methods and Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56c5a8b57cc45d1d222f8d418e134855
https://doi.org/10.1158/1535-7163.22505158
https://doi.org/10.1158/1535-7163.22505158
Autor:
James M. Reuben, Massimo Cristofanilli, Francisco J. Esteva, Sendurai A. Mani, Sabino De Placido, Naoto T. Ueno, Vicente Valero, Ricardo H. Alvarez, Charla A. Parker, Michele De Laurentiis, Sanda Tin, Bang-Ning Lee, Michal Mego, Evan Cohen, Simone Anfossi, Hui Gao, Antonio Giordano
PDF file - 64K, Gene expression levels of EMT-TFs in the tested cell lines (HMLE, HMLE-TWIST, MCF-7, BT-474, SKBR-3, MDA-MB-231)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::614a28cc4dd719936feab0907317e570
https://doi.org/10.1158/1535-7163.22496455
https://doi.org/10.1158/1535-7163.22496455
Autor:
James M. Reuben, Massimo Cristofanilli, Francisco J. Esteva, Sendurai A. Mani, Sabino De Placido, Naoto T. Ueno, Vicente Valero, Ricardo H. Alvarez, Charla A. Parker, Michele De Laurentiis, Sanda Tin, Bang-Ning Lee, Michal Mego, Evan Cohen, Simone Anfossi, Hui Gao, Antonio Giordano
PDF file - 86K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1be1c93d3bfa4125aaaaabf799d4cc52
https://doi.org/10.1158/1535-7163.22496452.v1
https://doi.org/10.1158/1535-7163.22496452.v1
Autor:
James M. Reuben, Massimo Cristofanilli, Francisco J. Esteva, Sendurai A. Mani, Sabino De Placido, Naoto T. Ueno, Vicente Valero, Ricardo H. Alvarez, Charla A. Parker, Michele De Laurentiis, Sanda Tin, Bang-Ning Lee, Michal Mego, Evan Cohen, Simone Anfossi, Hui Gao, Antonio Giordano
Currently, there is extensive information about circulating tumor cells (CTC) and their prognostic value; however, little is known about other characteristics of these cells. In this prospective study, we assessed the gene transcripts of epithelial-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14907bb695b18bdad63e76e969214945
https://doi.org/10.1158/1535-7163.c.6535276.v1
https://doi.org/10.1158/1535-7163.c.6535276.v1
Autor:
Eddy S. Yang, Susan E. Nozell, Albert F. LoBuglio, Rachel Schiff, C. Kent Osborne, Francisco J. Esteva, Andres Forero, Ling Zeng, Tiffiny S. Cooper, Rajani Rajbhandari, Zhuo Zhang, Monica E. Wielgos
SFigure1: HER2+ breast cancer cells are sensitive to nirparib SFigure2: HER2+ breast cancer microtumors are sensitive to ABT-888 SFigure3: (A) ABT-888 reduces PAR levels in HER2+ xenograft models. (B) ABT-888 did not cause weight loss in mice SFigure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::304cc460640481e9f8fa3bf07cd6c7b4
https://doi.org/10.1158/1535-7163.22505161.v1
https://doi.org/10.1158/1535-7163.22505161.v1
Autor:
Eddy S. Yang, Susan E. Nozell, Albert F. LoBuglio, Rachel Schiff, C. Kent Osborne, Francisco J. Esteva, Andres Forero, Ling Zeng, Tiffiny S. Cooper, Rajani Rajbhandari, Zhuo Zhang, Monica E. Wielgos
HER2-targeted therapies, such as trastuzumab, have increased the survival rates of HER2+ breast cancer patients. However, despite these therapies, many tumors eventually develop resistance to these therapies. Our lab previously reported an unexpected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9df9a768571b5e6ab0d20ae7ff72e7f0
https://doi.org/10.1158/1535-7163.c.6537973.v1
https://doi.org/10.1158/1535-7163.c.6537973.v1
Autor:
Sai-Ching J. Yeung, Gabriel N. Hortobagyi, Francisco J. Esteva, Aiham Z. Qdaisat, Xiaolan Dai, Jiali Ji, Xuexin He
Supplementary Data from Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18c9140e08abdcc6ef8d696a411dd245
https://doi.org/10.1158/1078-0432.22481421
https://doi.org/10.1158/1078-0432.22481421
Autor:
Hope S. Rugo, John W. Park, Francisco J. Esteva, Minetta C. Liu, P. Kelly Marcom, Erica L. Mayer, Mothaffar F. Rimawi, Janet H. Scott, Jimmy Hwang, Amy DeLuca, Lisa A. Carey, Mark Jesus M. Magbanua
Purpose: Recent developments in rare-cell technology have led to improved blood-based assays that allow for the reliable detection, enumeration, and more recently, genomic profiling of circulating tumor cells (CTC). We evaluated two different approac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bf49a776e9031049580fdd6286a8dfe
https://doi.org/10.1158/1078-0432.c.6524924
https://doi.org/10.1158/1078-0432.c.6524924